{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:40:59Z","timestamp":1765291259854,"version":"3.46.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Italian Ministry of Health, Ricerca Corrente"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01881-2","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:36:16Z","timestamp":1765290976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A TAp63alpha truncating variant associated with primary ovarian insufficiency lowers the cellular apoptotic rate"],"prefix":"10.1186","volume":"18","author":[{"given":"Silvia","family":"Moleri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Casafina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"2","key":"1881_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","volume":"26","author":"M Li","year":"2023","unstructured":"Li M, Zhu Y, Wei J, Chen L, Chen S, Lai D. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2023;26(2):95\u2013102.","journal-title":"Climacteric"},{"issue":"4","key":"1881_CR2","first-page":"604","volume":"67","author":"CB Coulam","year":"1986","unstructured":"Coulam CB, Adamson SC, Annegers. J F. Incidence of premature ovarian failure. Obstetrical Gynecol Surv Aprile. 1986;67(4):604\u20136.","journal-title":"Obstetrical Gynecol Surv Aprile"},{"issue":"6","key":"1881_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tem.2018.03.010","volume":"29","author":"I Huhtaniemi","year":"2018","unstructured":"Huhtaniemi I, Hovatta O, La Marca A, Livera G, Monniaux D, Persani L. Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency. Trends Endocrinol Metab. 2018;29(6):400\u201319.","journal-title":"Trends Endocrinol Metab"},{"issue":"S1","key":"1881_CR4","first-page":"59","volume":"23","author":"S Federici","year":"2022","unstructured":"Federici S, Persani L, Bonomi M. Approccio Diagnostico Alla Paziente Con insufficienza ovarica primaria. LEndocrinologo. 2022;23(S1):59\u201362.","journal-title":"LEndocrinologo"},{"key":"1881_CR5","doi-asserted-by":"crossref","unstructured":"Rossetti R, Moleri S, Guizzardi F, Gentilini D, Libera L, Marozzi A et al. Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset. Front Endocrinol (Lausanne). 2021;12:664645. 20211104a.","DOI":"10.3389\/fendo.2021.664645"},{"key":"1881_CR6","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a MM, Funari MFA, Lerario AM, Santos MG, Nishi MY, Domenice S et al. Screening of targeted panel genes in Brazilian patients with primary ovarian insufficiency. PLoS One. 2020;15:e0240795. 20201023a.","DOI":"10.1371\/journal.pone.0240795"},{"issue":"3","key":"1881_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1086\/323123","volume":"69","author":"H Van Bokhoven","year":"2001","unstructured":"Van Bokhoven H, Hamel BCJ, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PHG, et al. P63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand\u2013split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet. 2001;69(3):481\u201392.","journal-title":"Am J Hum Genet"},{"issue":"15","key":"1881_CR8","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/ajmg.a.32371","volume":"146A","author":"L Guazzarotti","year":"2008","unstructured":"Guazzarotti L, Caprio C, Rinne TK, Bosoni M, Pattarino G, Mauri S, et al. Limb-mammary syndrome (LMS) associated with internal female genitalia dysgenesia: a new genotype\/phenotype correlation? Am J Med Genet A. 2008;146A(15):2001\u20134.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"1881_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/sj.ejhg.5201888","volume":"15","author":"M Holder-Espinasse","year":"2007","unstructured":"Holder-Espinasse M, Martin-Coignard D, Escande F, Manouvrier-Hanu S. A new mutation in TP63 is associated with age-related pathology. Eur J Hum Genet. 2007;15(11):1115\u201320.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"1881_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cge.13725","volume":"97","author":"SW Mathorne","year":"2020","unstructured":"Mathorne SW, Ravn P, Hansen D, Beck-Nielsen SS, Gj\u00f8rup H, S\u00f8rensen KP, et al. Novel phenotype of syndromic premature ovarian insufficiency associated with TP63 molecular defect. Clin Genet. 2020;97(5):779\u201384.","journal-title":"Clin Genet"},{"key":"1881_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/humrep\/dey389","volume":"34","author":"I Bestetti","year":"2019","unstructured":"Bestetti I, Castronovo C, Sironi A, Caslini C, Sala C, Rossetti R, et al. High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function. Hum Reprod. 2019;34:574\u201383.","journal-title":"Hum Reprod"},{"key":"1881_CR12","doi-asserted-by":"crossref","unstructured":"Tucker EJ, Jaillard S, Grover SR, van den Bergen J, Robevska G, Bell KM et al. TP63-truncating variants cause isolated premature ovarian insufficiency. Hum Mutat. 2019;40:886\u201392. 20190329a","DOI":"10.1002\/humu.23744"},{"key":"1881_CR13","doi-asserted-by":"crossref","unstructured":"Huang C, Zhao S, Yang Y, Guo T, Ke H, Mi X et al. TP63 gain-of-function mutations cause premature ovarian insufficiency by inducing oocyte apoptosis [Internet]. J Clin Invest. 2023;133: 20230301a\u00a0Disponibile su: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36856110.","DOI":"10.1172\/JCI162315"},{"key":"1881_CR14","doi-asserted-by":"publisher","first-page":"104246","DOI":"10.1016\/j.ebiom.2022.104246","volume":"84","author":"A Heddar","year":"2022","unstructured":"Heddar A, Ogur C, Da Costa S, Braham I, Billaud-Rist L, Findikli N, et al. Genetic landscape of a large cohort of primary ovarian insufficiency: new genes and pathways and implications for personalized medicine. eBioMedicine Ottobre. 2022;84:104246.","journal-title":"eBioMedicine Ottobre"},{"key":"1881_CR15","doi-asserted-by":"crossref","unstructured":"Vanderschelden RK, Rodriguez-Escriba M, Chan SH, Berman AJ, Rajkovic A, Yatsenko SA. Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency. J Assist Reprod Genet. 2023;40:2211\u20138. 20230715a.","DOI":"10.1007\/s10815-023-02886-w"},{"key":"1881_CR16","doi-asserted-by":"crossref","unstructured":"Fisher ML, Balinth S, Mills AA. p63-related signaling at a glance. Journal of cell science [Internet]. 2020;133(17). Disponibile su: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32917730.","DOI":"10.1242\/jcs.228015"},{"issue":"3","key":"1881_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1471-4914(01)02260-2","volume":"8","author":"H Van Bokhoven","year":"2002","unstructured":"Van Bokhoven H, McKeon F. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol Med. 2002;8(3):133\u20139.","journal-title":"Trends Mol Med"},{"issue":"3","key":"1881_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030536","volume":"13","author":"C Osterburg","year":"2021","unstructured":"Osterburg C, Osterburg S, Zhou H, Missero C, D\u00f6tsch V. Isoform-specific roles of mutant p63 in human diseases. Cancers. 2021;13(3):536.","journal-title":"Cancers"},{"key":"1881_CR19","doi-asserted-by":"crossref","unstructured":"Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z et al. p63 protects the female germ line during meiotic arrest. Nature. 2006;444:624\u20138. 20061122a.","DOI":"10.1038\/nature05337"},{"issue":"4","key":"1881_CR20","first-page":"566","volume":"144","author":"GB Deutsch","year":"2011","unstructured":"Deutsch GB, Zielonka EM, Coutandin D, Weber TA, Sch\u00e4fer B, Hannewald J, et al. DNA damage in oocytes induces a switch of the quality control factor TAp63\u03b1 from dimer to tetramer. Cell Febbraio. 2011;144(4):566\u201376.","journal-title":"Cell Febbraio"},{"issue":"3","key":"1881_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","volume":"26","author":"SY Kim","year":"2019","unstructured":"Kim SY, Nair DM, Romero M, Serna VA, Koleske AJ, Woodruff TK, et al. Transient Inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies. Cell Death Differ Marzo. 2019;26(3):502\u201315.","journal-title":"Cell Death Differ Marzo"},{"issue":"13","key":"1881_CR22","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/sj.emboj.7600708","volume":"24","author":"G Olav","year":"2005","unstructured":"Olav G, Tobias S, Katja L, Elisa SS, Andreas K, Henning SB, et al. TAp63\u03b1 induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 2005;24(13):2458\u201371.","journal-title":"EMBO J"},{"issue":"24","key":"1881_CR23","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.4161\/cc.22819","volume":"11","author":"I Amelio","year":"2012","unstructured":"Amelio I, Grespi F, Annicchiarico-Petruzzelli M, Melino G. P63 the guardian of human reproduction. Cell Cycle. 2012;11(24):4545\u201351.","journal-title":"Cell Cycle"},{"key":"1881_CR24","doi-asserted-by":"crossref","unstructured":"Lena AM, Rossi V, Osterburg S, Smirnov A, Osterburg C, Tuppi M et al. The p63 C-terminus is essential for murine oocyte integrity. Nat Commun. 2021;12:383. 20210115a.","DOI":"10.1038\/s41467-020-20669-0"},{"key":"1881_CR25","doi-asserted-by":"crossref","unstructured":"Nanda A, AlLafi A, Wolf S, AlMasry IM, Betz R. TP63-related disorders: two case reports and a brief review of the literature. Dermatology online journal [Internet]. 2021;27(11). Disponibile su: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35130400.","DOI":"10.5070\/D3271156088"},{"key":"1881_CR26","doi-asserted-by":"crossref","unstructured":"Tucker EJ, Gutfreund N, Belaud-Rotureau MA, Gilot D, Brun T, Kline BL et al. Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency. Hum Mutat. 2022;43:1443\u201353. 20220729a.","DOI":"10.1002\/humu.24432"},{"issue":"3","key":"1881_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/MCB.24.3.1341-1350.2004","volume":"24","author":"D Bergamaschi","year":"2004","unstructured":"Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X. ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol. 2004;24(3):1341\u201350.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1881_CR28","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1172\/JCI40266","volume":"120","author":"HA Thomason","year":"2010","unstructured":"Thomason HA, Zhou H, Kouwenhoven EN, Dotto GP, Restivo G, Nguyen BC, et al. Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J Clin Invest. 2010;120(5):1561\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"1881_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2164-12-57","volume":"12","author":"A Regassa","year":"2011","unstructured":"Regassa A, Rings F, Hoelker M, Cinar U, Tholen E, Looft C, et al. Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells. BMC Genomics. 2011;12(1):57\u201357.","journal-title":"BMC Genomics"},{"issue":"5","key":"1881_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.jid.5700652","volume":"127","author":"RA Romano","year":"2007","unstructured":"Romano RA, Birkaya B, Sinha S. A functional enhancer of Keratin14 is a direct transcriptional target of \u2206Np63. J Invest Dermatology. 2007;127(5):1175\u201386.","journal-title":"J Invest Dermatology"},{"issue":"16","key":"1881_CR31","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/1873-3468.12275","volume":"590","author":"G Livera","year":"2016","unstructured":"Livera G, Uzbekov R, Jarrier P, Fouch\u00e9court S, Duquenne C, Parent A, et al. Loss of oocytes due to conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in female sterility. FEBS Lett. 2016;590(16):2566\u201374.","journal-title":"FEBS Lett"},{"issue":"2","key":"1881_CR32","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1096\/fj.201801401R","volume":"33","author":"H Haraguchi","year":"2019","unstructured":"Haraguchi H, Hirota Y, Saito-Fujita T, Tanaka T, Shimizu-Hirota R, Harada M, et al. Mdm2-p53\u2010SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality. FASEB J. 2019;33(2):2610\u201320.","journal-title":"FASEB J"},{"issue":"1","key":"1881_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mce.2009.11.013","volume":"317","author":"M J\u00e4\u00e4skel\u00e4inen","year":"2010","unstructured":"J\u00e4\u00e4skel\u00e4inen M, Prunskaite-Hyyryl\u00e4inen R, Naillat F, Parviainen H, Anttonen M, Heikinheimo M, et al. WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival. Mol Cell Endocrinol. 2010;317(1):106\u201311.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"1881_CR34","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1096\/fj.09-145789","volume":"24","author":"B Alexandre","year":"2010","unstructured":"Alexandre B, \u00c9velyne L, Xiaofeng Z, Robert GC, Huaiguang L, Susan MQ, et al. WNT4 is required for normal ovarian follicle development and female fertility. FASEB J. 2010;24(8):3010\u201325.","journal-title":"FASEB J"},{"issue":"3","key":"1881_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ygyno.2006.02.014","volume":"101","author":"AA Secord","year":"2006","unstructured":"Secord AA, Lee PS, Darcy KM, Havrilesky LJ, Grace LA, Marks JR, et al. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a gynecologic oncology group study. Gynecol Oncol. 2006;101(3):390\u20137.","journal-title":"Gynecol Oncol"},{"key":"1881_CR36","doi-asserted-by":"crossref","unstructured":"Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, et al. editors. \u2019s Note: The Paradoxical Expression of Maspin in Ovarian Carcinoma. Clinical Cancer Research. 1 agosto 2021;27(15):4456\u20134456.","DOI":"10.1158\/1078-0432.CCR-21-2122"},{"issue":"1","key":"1881_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmx029","volume":"24","author":"D Richani","year":"2018","unstructured":"Richani D, Gilchrist RB. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Hum Reprod Update. 2018;24(1):1\u201314.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"1881_CR38","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1074\/jbc.M107173200","volume":"277","author":"V Calabr\u00f2","year":"2002","unstructured":"Calabr\u00f2 V, Mansueto G, Parisi T, Vivo M, Calogero RA, La Mantia G. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J Biol Chem. 2002;277(4):2674\u201381.","journal-title":"J Biol Chem"},{"issue":"12","key":"1881_CR39","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/ajmg.a.34335","volume":"155","author":"V Serra","year":"2011","unstructured":"Serra V, Castori M, Paradisi M, Bui L, Melino G, Terrinoni A. Functional characterization of a novel TP63 mutation in a family with overlapping features of Rapp-Hodgkin\/AEC\/ADULT syndromes. Am J Med Genet A. 2011;155(12):3104\u20139.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"1881_CR40","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/humu.20961","volume":"30","author":"R Rossetti","year":"2009","unstructured":"Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, et al. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat Maggio. 2009;30(5):804\u201310.","journal-title":"Hum Mutat Maggio"},{"issue":"3","key":"1881_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/cc.6.3.3802","volume":"6","author":"MA Vigan\u00f2","year":"2007","unstructured":"Vigan\u00f2 MA, Mantovani R. Hitting the numbers: the emerging network of p63 targets. Cell Cycle. 2007;6(3):233\u20139.","journal-title":"Cell Cycle"},{"issue":"5","key":"1881_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1006\/bbrc.2001.4905","volume":"283","author":"M Osada","year":"2001","unstructured":"Osada M, Inaba R, Shinohara H, Hagiwara M, Nakamura M, Ikawa Y. Regulatory Domain of Protein Stability of Human P51\/TAP63, a P53 Homologue. Biochem Biophys Res Commun maggio. 2001;283(5):1135\u201341.","journal-title":"Biochem Biophys Res Commun. maggio."},{"issue":"24","key":"1881_CR43","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.1128\/MCB.22.24.8601-8611.2002","volume":"22","author":"Z Serber","year":"2002","unstructured":"Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, et al. A c-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol. 2002;22(24):8601\u201311.","journal-title":"Mol Cell Biol"},{"key":"1881_CR44","doi-asserted-by":"crossref","unstructured":"Leem J, Lee C, Choi DY, Oh JS. Distinct characteristics of the DNA damage response in mammalian oocytes. Exp Mol Med. 14 febbraio. 2024;56(2):319\u201328.","DOI":"10.1038\/s12276-024-01178-2"},{"issue":"1","key":"1881_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ydbio.2008.10.031","volume":"325","author":"JL Sabel","year":"2009","unstructured":"Sabel JL, d\u2019Alen\u00e7on C, O\u2019Brien EK, Van Otterloo E, Lutz K, Cuykendall TN, et al. Maternal interferon regulatory factor 6 is required for the differentiation of primary superficial epithelia in Danio and xenopus embryos. Dev Biol. 2009;325(1):249\u201362.","journal-title":"Dev Biol"},{"issue":"4","key":"1881_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/gene.20016","volume":"38","author":"M Hafner","year":"2004","unstructured":"Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N, et al. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. genesis. 2004;38(4):176\u201381.","journal-title":"genesis"},{"issue":"22","key":"1881_CR47","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1242\/jcs.03265","volume":"119","author":"E Candi","year":"2006","unstructured":"Candi E, Terrinoni A, Rufini A, Chikh A, Lena AM, Suzuki Y, et al. p63 is upstream of IKK\u03b1 in epidermal development. J Cell Sci 15 Novembre. 2006;119(22):4617\u201322.","journal-title":"J Cell Sci 15 Novembre"},{"issue":"4","key":"1881_CR48","doi-asserted-by":"publisher","first-page":"e0152837","DOI":"10.1371\/journal.pone.0152837","volume":"11","author":"L Li","year":"2016","unstructured":"Li L, Mo H, Zhang J, Zhou Y, Peng X, Luo X. The role of heat shock protein 90B1 in patients with polycystic ovary Syndrome. Picard D, curatore. PLoS ONE 5 Aprile. 2016;11(4):e0152837.","journal-title":"PLoS ONE 5 Aprile"},{"key":"1881_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2023.08.004","volume":"677","author":"M Hui","year":"2023","unstructured":"Hui M, Hu S, Ye L, Zhang M, Jing X, Hong Y. PAK2\/beta-catenin\/c-Myc\/PKM2 signal transduction suppresses ovarian granulosa cell apoptosis in polycystic ovary syndrome. Biochem Biophys Res Commun Ottobre. 2023;677:54\u201362.","journal-title":"Biochem Biophys Res Commun Ottobre"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01881-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:36:20Z","timestamp":1765290980000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01881-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01881-2","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for blood sampling and genetic investigations, approved by the Ethical Clinical Research Committees of IRCCS Istituto Auxologico Italiano (BIOEFFECT, code 05M101_2014), was obtained from patients and their relatives. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}